Dextromethorphan Hydrobromide/Quinidine Sulfate (剂泰医药)

氢溴酸右美沙芬/硫酸奎尼丁口崩片（剂泰医药）

Report date: 2026/02/10 20:00:22

Base Information

Drug NameDextromethorphan Hydrobromide/Quinidine Sulfate (剂泰医药)
Drug Alias NameMTS004 口崩片MTS004口崩片（2.2类改良型新药）MTS-004MTS004MTS 004 ODT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsCytochrome P450 2D6 inhibitorsSigma opioid receptor agonists
TargetsGlutamate [NMDA] receptorCytochrome P450 2D6Sigma opioid receptor
Therapy Area/IndicationsPseudobulbar PalsyStrokeDeglutition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMETiS Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesMETiS Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsPseudobulbar PalsyStrokeDeglutition Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A